Skip to main content
Catalog Models

Humanized Immune Checkpoint Mice

Humanized immune checkpoint models enable preclinical testing of human specific checkpoint inhibitor antibodies in immunocompetent mice.

Request a Quote

Available Checkpoint Models

PD1 Humanized Mice

PDCD1

Enables testing of anti PD1 antibodies including pembrolizumab and nivolumab.

Learn more

PDL1 Humanized Mice

CD274

Enables testing of anti PDL1 antibodies including atezolizumab, durvalumab, and avelumab.

Learn more

CTLA4 Humanized Mice

CTLA4

Enables testing of anti CTLA4 antibodies including ipilimumab.

Learn more

LAG3 Humanized Mice

CD223

Supports development of anti LAG3 antibodies as single agents and in combination with PD1 blockade.

Learn more

TIM3 Humanized Mice

HAVCR2

Enables testing of anti TIM3 antibodies as emerging checkpoint targets.

Learn more

Combination Checkpoint Models

PD1/CTLA4 Double Humanized

Testing combinations similar to nivolumab plus ipilimumab

PD1/LAG3 Double Humanized

Next generation combination therapies

Triple Checkpoint Models

Multi agent regimens testing

Custom Combinations

Tailored to specific immunotherapy programs

Humanization Strategies

Extracellular Domain Humanization

Humanizes the extracellular domain where therapeutic antibodies bind while retaining mouse transmembrane and intracellular domains. Maintains normal signaling while enabling human antibody binding.

Complete Gene Replacement

Complete replacement with the human gene provides a fully humanized target. Preferred when studying antibodies that modulate signaling or when complete humanization is required.

Tumor Model Compatibility

C57BL/6 Background

Compatible lines: MC38 (colon), B16 (melanoma), E0771 (breast), Lewis lung carcinoma

BALB/c Background

Compatible lines: CT26 (colon), 4T1 (breast), Renca (kidney)

What Researchers Say

iTL produced a new conditional mouse model for us and the quality of service was exceptional. The team is extremely knowledgeable and the work was completed at the highest possible standards. My project manager was excellent and always happy to answer technical questions and keep me up to date with progress and potential problems. I would recommend iTL highly and will use them again in the future if I need to generate a new mouse line.

Albert Basson, PhD

King's College London

Start Your Checkpoint Model Project

Ready to discuss humanized checkpoint models for your immunotherapy program? Our scientific team provides complimentary consultation to help you select the optimal checkpoint model design.

Frequently asked questions

Most clinical checkpoint inhibitor antibodies are designed to target human proteins and do not cross react with mouse orthologs. Humanized checkpoint models express human PD1, PDL1, CTLA4, or other targets, enabling efficacy testing of clinical antibodies in immunocompetent mice with functional immune systems.

We offer humanized models for PD1, PDL1, CTLA4, LAG3, TIM3, and other checkpoints, as well as single and dual checkpoint combinations. Catalog models provide study ready mice with shorter lead times than custom projects.

Yes. Dual or triple humanized checkpoint mice are commonly used for combination therapy studies. For example, PD1/CTLA4 double humanized mice enable testing of dual checkpoint blockade, which is increasingly important in clinical practice.

Humanized checkpoint models on C57BL/6 background are compatible with MC38, B16, E0771, and Lewis lung carcinoma. BALB/c models are compatible with CT26 and 4T1 tumors. Syngeneic tumor compatibility enables evaluation of checkpoint inhibitors in immunocompetent mice.

Related resources